𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose-escalation study of single dose mitoxantrone in combination with timed sequential chemotherapy in patients with refractory or relapsing acute myelogenous leukemia

✍ Scribed by X Thomas; N Cambier; A.L Taksin; O Reman; A Vekhoff; C Pautas; V Leblond; P Soler-Michel; E Ecstein-Fraı̈ssé; E Archimbaud

Book ID
114118896
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
77 KB
Volume
24
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose liposomal daunorubicin and hig
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
✍ Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Background: Liposomal encapsulation of daunorubicin (daunoxome, dnx; nexstar pharmaceutical, boulder, co) changes the pharmacology profile to increase delivery to tumor sites and decrease toxicity. the authors investigated the effect of daunorubicin in combination with ara-c in patients with ref

Treatment of relapsed or refractory acut
Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytine
✍ Leblanc, Thierry ;Deméocq, François ;Leverger, Guy ;Baruchel, André ;Lemerle, So 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

## Abstract Bisantrene is an anthracene derivative which has demonstrated activity in acute myeloblastic leukemia (AML) and in lymphoma. The present study was designed to assess the reinduction rate and toxicity of bisantrene (250 mg/m^2^/d × 5) associated with aracytine (1000 mg/m^2^ twice a day ×

Combination chemotherapy with low-dose c
Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia
✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient